$1.11 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 34 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SBGI | Exit | SINCLAIR BROADCAST GROUP INCcall | $0 | – | -74,200 | -100.0% | -0.24% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -18,000 | -100.0% | -0.50% | – |
| EQIX | Exit | EQUINIX INCcall | $0 | – | -42,500 | -100.0% | -0.94% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -76,000 | -100.0% | -1.19% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -213,800 | -100.0% | -1.34% | – |
| MYL | Exit | MYLAN INC | $0 | – | -306,900 | -100.0% | -1.78% | – |
| BEN | Exit | FRANKLIN RES INC | $0 | – | -312,400 | -100.0% | -2.01% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -263,300 | -100.0% | -2.05% | – |
| SBH | Exit | SALLY BEAUTY HLDGS INC | $0 | – | -636,000 | -100.0% | -2.07% | – |
| GNCIQ | Exit | GNC HLDGS INC | $0 | – | -461,600 | -100.0% | -2.42% | – |
| DG | Exit | DOLLAR GEN CORP NEW | $0 | – | -456,500 | -100.0% | -3.01% | – |
| UNP | Exit | UNION PAC CORP | $0 | – | -160,500 | -100.0% | -3.58% | – |
| EBAY | Exit | EBAY INC | $0 | – | -606,100 | -100.0% | -3.98% | – |
| IAC | Exit | IAC INTERACTIVECORP | $0 | – | -531,800 | -100.0% | -4.52% | – |
| EQIX | Exit | EQUINIX INC | $0 | – | -209,600 | -100.0% | -4.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-28 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.